Literature DB >> 23208728

Neuroimaging in mitochondrial disorders.

Andrea L Gropman1.   

Abstract

Mutations in either nuclear DNA or mitochondrial DNA can result in disruption of oxidative phosphorylation and lead to mitochondrial dysfunction. Mitochondrial disease manifestations occur predominantly in the central nervous system, peripheral nervous system, and/or involve several organ systems. The consequences range from manifestations of a single organ or tissues, such as muscle fatigue, if confined only to muscle, seizures, intellectual disabilities, dementia, and stroke (if to the central nervous system), leading to disability or even early death. The definitive diagnosis of a mitochondrial disorder can be difficult to establish. Criteria and checklists have been established and are more reflective of adult disease. However, in children, when symptoms suggest a mitochondrial disease, neuroimaging features may have more diagnostic impact and additionally these can be used to follow the course, evolution, and recovery of the disease. This review will demonstrate the common neuroimaging patterns in patients with mitochondrial disorders and point out how various newer neuroimaging modalities may be exploited to glean information as to the different aspects of mitochondrial dysfunction or resulting neurological and cognitive disruption, although reports in the literature using these methods remain sparse.

Entities:  

Mesh:

Year:  2013        PMID: 23208728      PMCID: PMC3625392          DOI: 10.1007/s13311-012-0161-6

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  79 in total

1.  Tract-based spatial statistical analysis of diffusion tensor imaging in pediatric patients with mitochondrial disease: widespread reduction in fractional anisotropy of white matter tracts.

Authors:  G E Ishak; A V Poliakov; S L Poliachik; R P Saneto; E J Novotny; S McDaniel; J G Ojemann; D W W Shaw; S D Friedman
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

2.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

Review 3.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

4.  MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations.

Authors:  Laura Farina; Luisa Chiapparini; Graziella Uziel; Marianna Bugiani; Massimo Zeviani; Mario Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

5.  Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI.

Authors:  N Brunetti-Pierri; K Selby; M O'Sullivan; G Hendson; C Truong; P J Waters; L-J Wong
Journal:  Neuropediatrics       Date:  2008-11-07       Impact factor: 1.947

6.  Periventricular low intensities on fluid attenuated inversion recovery imaging in the newborn infant: Relationships to chronic white matter lesions.

Authors:  Osuke Iwata; Sachiko Iwata; Masanori Tamura; Tomohiko Nakamura; Shinnichi Hirabayashi; Noboru Fueki; Yoshiaki Kondou; Hideki Kihara
Journal:  Pediatr Int       Date:  2004-04       Impact factor: 1.524

7.  Dysmyelinating leukodystrophies: "LACK Proper Myelin".

Authors:  H P Hatten
Journal:  Pediatr Radiol       Date:  1991

Review 8.  Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies.

Authors:  Maria Cristina Bianchi; Giuseppina Sgandurra; Michela Tosetti; Roberta Battini; Giovanni Cioni
Journal:  Biosci Rep       Date:  2007-06       Impact factor: 3.840

Review 9.  The in-depth evaluation of suspected mitochondrial disease.

Authors:  Richard H Haas; Sumit Parikh; Marni J Falk; Russell P Saneto; Nicole I Wolf; Niklas Darin; Lee-Jun Wong; Bruce H Cohen; Robert K Naviaux
Journal:  Mol Genet Metab       Date:  2008-02-01       Impact factor: 4.797

10.  MR of the brain in mitochondrial myopathy.

Authors:  S H Wray; J M Provenzale; D R Johns; K R Thulborn
Journal:  AJNR Am J Neuroradiol       Date:  1995-05       Impact factor: 3.825

View more
  19 in total

1.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

Review 2.  When to Suspect and How to Diagnose Mitochondrial Disorders?

Authors:  Sergei Korenev; Andrew A M Morris
Journal:  Indian J Pediatr       Date:  2016-01-13       Impact factor: 1.967

3.  Selective galactose culture condition reveals distinct metabolic signatures in pyruvate dehydrogenase and complex I deficient human skin fibroblasts.

Authors:  Damian Hertig; Andrea Felser; Gaëlle Diserens; Sandra Kurth; Peter Vermathen; Jean-Marc Nuoffer
Journal:  Metabolomics       Date:  2019-02-28       Impact factor: 4.290

Review 4.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

5.  Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.

Authors:  Feng-Nan Niu; Hai-Lan Meng; Lei-Lei Chang; Hong-Yan Wu; Wei-Ping Li; Ren-Yuan Liu; Hui-Ting Wang; Bing Zhang; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2017-07-11       Impact factor: 5.243

Review 6.  Mitochondrial dysfunction in inherited renal disease and acute kidney injury.

Authors:  Francesco Emma; Giovanni Montini; Samir M Parikh; Leonardo Salviati
Journal:  Nat Rev Nephrol       Date:  2016-01-25       Impact factor: 28.314

7.  A diagnostic approach for cerebral palsy in the genomic era.

Authors:  Ryan W Lee; Andrea Poretti; Julie S Cohen; Eric Levey; Hilary Gwynn; Michael V Johnston; Alexander H Hoon; Ali Fatemi
Journal:  Neuromolecular Med       Date:  2014-10-04       Impact factor: 3.843

8.  Lesional perfusion abnormalities in Leigh disease demonstrated by arterial spin labeling correlate with disease activity.

Authors:  Matthew T Whitehead; Bonmyong Lee; Andrea Gropman
Journal:  Pediatr Radiol       Date:  2016-04-04

9.  Expanding Role of Proton Magnetic Resonance Spectroscopy: Timely Diagnosis and Treatment Initiation in Partial Ornithine Transcarbamylase Deficiency.

Authors:  Kuntal Sen; Carlos Castillo Pinto; Andrea L Gropman
Journal:  J Pediatr Genet       Date:  2020-04-23

10.  Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.

Authors:  Laura L Gramegna; Stefania Evangelisti; Lidia Di Vito; Chiara La Morgia; Alessandra Maresca; Leonardo Caporali; Giulia Amore; Lia Talozzi; Claudio Bianchini; Claudia Testa; David N Manners; Irene Cortesi; Maria L Valentino; Rocco Liguori; Valerio Carelli; Caterina Tonon; Raffaele Lodi
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.